Sale!

ARFGEF2 Gene Periventricular Heterotopia with Microcephaly Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ARFGEF2 Gene Periventricular Heterotopia with Microcephaly Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the ARFGEF2 gene. These mutations are associated with the development of Periventricular Heterotopia (PH) accompanied by microcephaly, a rare genetic disorder. PH is characterized by the presence of nodules of neurons in inappropriate locations in the brain due to their failure to migrate to the correct positions during development. This condition can lead to a range of neurological issues, including seizures, developmental delay, and difficulties with coordination and balance. Microcephaly, on the other hand, is a condition where a baby’s head is significantly smaller than expected, often due to abnormal brain development.

The test, which costs 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the ARFGEF2 gene that are known to cause this complex condition. The results from this genetic testing can provide crucial information for the diagnosis, management, and understanding of the patient’s condition. It can also offer valuable insights for family planning and genetic counseling for families affected by Periventricular Heterotopia with microcephaly. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable testing results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ARFGEF2 Gene Periventricular heterotopia with microcephaly Genetic Test

The ARFGEF2 gene is associated with a condition called periventricular heterotopia with microcephaly. Periventricular heterotopia is a brain malformation characterized by the presence of nodules of gray matter located along the lateral ventricles, instead of being properly positioned within the cerebral cortex. Microcephaly refers to a smaller than average head size.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify mutations or variations that may be associated with a particular condition. In the case of periventricular heterotopia with microcephaly, NGS genetic testing can be used to examine the ARFGEF2 gene for any mutations or variations that may be causing the condition.

This type of genetic testing can provide valuable information for diagnosing individuals with periventricular heterotopia with microcephaly and can also help determine the mode of inheritance, provide information for genetic counseling, and potentially guide treatment options. It is typically performed by obtaining a blood or saliva sample from the individual being tested and analyzing the DNA for any genetic abnormalities in the ARFGEF2 gene.

Test Details

  • Test Name: ARFGEF2 Gene Periventricular heterotopia with microcephaly Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for ARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ARFGEF2 Gene Periventricular heterotopia with microcephaly.

Test Process

The test involves obtaining a blood or saliva sample from the individual being tested. The sample is then analyzed using NGS technology to examine the ARFGEF2 gene for any mutations or variations that may be causing periventricular heterotopia with microcephaly. The test results are typically delivered within 3 to 4 weeks.

Conclusion

The ARFGEF2 Gene Periventricular heterotopia with microcephaly Genetic Test is a valuable tool for diagnosing individuals with periventricular heterotopia with microcephaly. It can provide important information for genetic counseling, determining the mode of inheritance, and guiding treatment options. The test is performed by analyzing a blood or saliva sample using NGS technology. The cost of the test is 4400.0 AED.

Test Name ARFGEF2 Gene Periventricular heterotopia with microcephaly Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ARFGEF2 Gene Periventricular heterotopia with microcephaly NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ARFGEF2 Gene Periventricular heterotopia with microcephaly
Test Details

The ARFGEF2 gene is associated with a condition called periventricular heterotopia with microcephaly. Periventricular heterotopia is a brain malformation characterized by the presence of nodules of gray matter located along the lateral ventricles, instead of being properly positioned within the cerebral cortex. Microcephaly refers to a smaller than average head size.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify mutations or variations that may be associated with a particular condition. In the case of periventricular heterotopia with microcephaly, NGS genetic testing can be used to examine the ARFGEF2 gene for any mutations or variations that may be causing the condition.

This type of genetic testing can provide valuable information for diagnosing individuals with periventricular heterotopia with microcephaly and can also help determine the mode of inheritance, provide information for genetic counseling, and potentially guide treatment options. It is typically performed by obtaining a blood or saliva sample from the individual being tested and analyzing the DNA for any genetic abnormalities in the ARFGEF2 gene.